Cite
Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
MLA
Michael J. Gubbins, et al. “Development and Characterisation of Neutralising Monoclonal Antibody to the SARS-Coronavirus.” Journal of Virological Methods, vol. 120, no. 1, June 2004, pp. 87–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d15d3f951351f1c442ff2db87ef8d5e&authtype=sso&custid=ns315887.
APA
Michael J. Gubbins, Amin Kabani, Hana M. Weingartl, Marta I. Sabara, Jason Gren, Anton Andonov, Francesca Ranada, Michael Drebot, T. Blake Ball, Yan Li, Lisa Fernando, Jody D. Berry, Frank Plummer, Peter Marszal, Paul Kitching, Brigitte Nicolas, Steven M. Jones, Xin Y. Yuan, & Maya Andonova. (2004). Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of Virological Methods, 120(1), 87–96.
Chicago
Michael J. Gubbins, Amin Kabani, Hana M. Weingartl, Marta I. Sabara, Jason Gren, Anton Andonov, Francesca Ranada, et al. 2004. “Development and Characterisation of Neutralising Monoclonal Antibody to the SARS-Coronavirus.” Journal of Virological Methods 120 (1): 87–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0d15d3f951351f1c442ff2db87ef8d5e&authtype=sso&custid=ns315887.